Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

14-3-3 protein binding blocks the dimerization interface of caspase-2

D. Kalabova, F. Filandr, M. Alblova, O. Petrvalska, M. Horvath, P. Man, T. Obsil, V. Obsilova

. 2020 ; 287 (16) : 3494-3510. [pub] 20200204

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 2005 to 1 year ago
Medline Complete (EBSCOhost) from 2005-01-01 to 1 year ago
Wiley Free Content from 2005 to 1 year ago

Among all species, caspase-2 (C2) is the most evolutionarily conserved caspase required for effective initiation of apoptosis following death stimuli. C2 is activated through dimerization and autoproteolytic cleavage and inhibited through phosphorylation at Ser139 and Ser164 , within the linker between the caspase recruitment and p19 domains of the zymogen, followed by association with the adaptor protein 14-3-3, which maintains C2 in its immature form procaspase (proC2). However, the mechanism of 14-3-3-dependent inhibition of C2 activation remains unclear. Here, we report the structural characterization of the complex between proC2 and 14-3-3 by hydrogen/deuterium mass spectrometry and protein crystallography to determine the molecular basis for 14-3-3-mediated inhibition of C2 activation. Our data reveal that the 14-3-3 dimer interacts with proC2 not only through ligand-binding grooves but also through other regions outside the central channel, thus explaining the isoform-dependent specificity of 14-3-3 protein binding to proC2 and the substantially higher binding affinity of 14-3-3 protein to proC2 than to the doubly phosphorylated peptide. The formation of the complex between 14-3-3 protein and proC2 does not induce any large conformational change in proC2. Furthermore, 14-3-3 protein interacts with and masks both the nuclear localization sequence and the C-terminal region of the p12 domain of proC2 through transient interactions in which both the p19 and p12 domains of proC2 are not firmly docked onto the surface of 14-3-3. This masked region of p12 domain is involved in C2 dimerization. Therefore, 14-3-3 protein likely inhibits proC2 activation by blocking its dimerization surface. DATABASES: Structural data are available in the Protein Data Bank under the accession numbers 6SAD and 6S9K.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020294
003      
CZ-PrNML
005      
20211125091124.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/febs.15215 $2 doi
035    __
$a (PubMed)31961068
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kalabova, Dana $u Division BIOCEV, Department of Structural Biology of Signaling Proteins, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic
245    10
$a 14-3-3 protein binding blocks the dimerization interface of caspase-2 / $c D. Kalabova, F. Filandr, M. Alblova, O. Petrvalska, M. Horvath, P. Man, T. Obsil, V. Obsilova
520    9_
$a Among all species, caspase-2 (C2) is the most evolutionarily conserved caspase required for effective initiation of apoptosis following death stimuli. C2 is activated through dimerization and autoproteolytic cleavage and inhibited through phosphorylation at Ser139 and Ser164 , within the linker between the caspase recruitment and p19 domains of the zymogen, followed by association with the adaptor protein 14-3-3, which maintains C2 in its immature form procaspase (proC2). However, the mechanism of 14-3-3-dependent inhibition of C2 activation remains unclear. Here, we report the structural characterization of the complex between proC2 and 14-3-3 by hydrogen/deuterium mass spectrometry and protein crystallography to determine the molecular basis for 14-3-3-mediated inhibition of C2 activation. Our data reveal that the 14-3-3 dimer interacts with proC2 not only through ligand-binding grooves but also through other regions outside the central channel, thus explaining the isoform-dependent specificity of 14-3-3 protein binding to proC2 and the substantially higher binding affinity of 14-3-3 protein to proC2 than to the doubly phosphorylated peptide. The formation of the complex between 14-3-3 protein and proC2 does not induce any large conformational change in proC2. Furthermore, 14-3-3 protein interacts with and masks both the nuclear localization sequence and the C-terminal region of the p12 domain of proC2 through transient interactions in which both the p19 and p12 domains of proC2 are not firmly docked onto the surface of 14-3-3. This masked region of p12 domain is involved in C2 dimerization. Therefore, 14-3-3 protein likely inhibits proC2 activation by blocking its dimerization surface. DATABASES: Structural data are available in the Protein Data Bank under the accession numbers 6SAD and 6S9K.
650    _2
$a proteiny 14-3-3 $x chemie $x genetika $x metabolismus $7 D048948
650    _2
$a vazebná místa $x genetika $7 D001665
650    _2
$a kaspasa 2 $x chemie $x genetika $x metabolismus $7 D053143
650    _2
$a krystalografie rentgenová $7 D018360
650    _2
$a lidé $7 D006801
650    12
$a molekulární modely $7 D008958
650    _2
$a mutace $7 D009154
650    _2
$a fosforylace $7 D010766
650    _2
$a vazba proteinů $7 D011485
650    12
$a konformace proteinů $7 D011487
650    _2
$a protein - isoformy $x genetika $x metabolismus $7 D020033
650    12
$a multimerizace proteinu $7 D055503
650    _2
$a proteinové prekurzory $x chemie $x genetika $x metabolismus $7 D011498
650    _2
$a rekombinantní proteiny $x chemie $x metabolismus $7 D011994
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Filandr, Frantisek $u Division BIOCEV, Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic $u Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Alblová, Miroslava $u Division BIOCEV, Department of Structural Biology of Signaling Proteins, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic $7 xx0266819
700    1_
$a Petrvalska, Olivia $u Division BIOCEV, Department of Structural Biology of Signaling Proteins, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Horvath, Matej $u Division BIOCEV, Department of Structural Biology of Signaling Proteins, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Man, Petr $u Division BIOCEV, Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic
700    1_
$a Obsil, Tomas $u Division BIOCEV, Department of Structural Biology of Signaling Proteins, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Obsilova, Veronika $u Division BIOCEV, Department of Structural Biology of Signaling Proteins, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic
773    0_
$w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 287, č. 16 (2020), s. 3494-3510
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31961068 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20211125091126 $b ABA008
999    __
$a ok $b bmc $g 1690972 $s 1140740
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 287 $c 16 $d 3494-3510 $e 20200204 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...